摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

吡替尼定盐酸盐 | 100227-05-2

中文名称
吡替尼定盐酸盐
中文别名
——
英文名称
N-<1-octyl-4(1H)-pyridinylidene>octanamine monohydrochloride
英文别名
N-(1-octyl-4(1H)-pyridinylidene)octanamine monohydrochloride;N,1-dioctylpyridin-4-imine;hydron;chloride
吡替尼定盐酸盐化学式
CAS
100227-05-2
化学式
C21H38N2*ClH
mdl
——
分子量
355.007
InChiKey
BQXQJMORUIBOJL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.53
  • 重原子数:
    24
  • 可旋转键数:
    14
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.76
  • 拓扑面积:
    15.6
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:c0eae79b2d60a2208923560c38a937d4
查看

反应信息

  • 作为产物:
    描述:
    1-氯辛烷4-(辛基氨基)吡啶 反应 2.0h, 以94%的产率得到吡替尼定盐酸盐
    参考文献:
    名称:
    In vitro dental plaque inhibitory properties of a series of N-[1-alkyl-4(1H)-pyridinylidene]alkylamines
    摘要:
    A series of novel N-[1-alkyl-4(1H)-pyridinylidene]alkylamine hydrohalides has been prepared and evaluated as inhibitors of dental plaque formation, in vitro. Several members of the series exhibited potency ca. 9-fold greater than that of chlorhexidine vs Streptococcus sobrinus 6715-13. The di-n-octyl analogue, 11 (pirtenidine), was found to be highly efficacious against several other oral plaque-forming microorganisms and is presently undergoing preclinical evaluation.
    DOI:
    10.1021/jm00118a030
点击查看最新优质反应信息

文献信息

  • [EN] OCTENIDINE BASED COMPOUNDS<br/>[FR] COMPOSÉS À BASE D'OCTÉNIDINE
    申请人:DISHMAN CARBOGEN AMCIS LTD
    公开号:WO2019038669A1
    公开(公告)日:2019-02-28
    The present invention discloses Octenidine based compounds of formula (A) or formula (B) and formula(C) where in, n=1,2,3,4 and R'=un-substituted or substituted aryl or alkyl group; R is hydroxy or hydrogen, X is chlorine, bromine and iodine. The present invention also relates to a process for the preparation thereof.
    本发明披露了基于八亚甲基-4,5-二氮杂-2-丙醇(Octenidine)的化合物,其化学式为(A)或(B)和(C),其中n=1,2,3,4,R'=未取代或取代的芳基或烷基;R为羟基或氢,X为。本发明还涉及一种制备该化合物的方法。
  • Antimicrobial (N-1-octyl-4(1H)-pyridinylidine)octanamine and acid
    申请人:Sterling Drug Inc.
    公开号:US04598082A1
    公开(公告)日:1986-07-01
    N-[1-(alkyl or arylmethyl)-4(1H)-pyridinylidine]-alkanamine and pharmaceutically acceptable acid addition salts thereof, for example, N-(1-octyl-4(1H)-pyridinylidine)octanamine monohydrochloride salt, which are useful as antimicrobial agents, especially on living tissues and nonliving surfaces and most especially against pathogenic dental microbes, and a process for preparation, methods of use and compositions thereof are disclosed.
    本发明涉及一种N-[1-(烷基或芳基甲基)-4(1H)-吡啶亚胺基]-烷基胺及其药学上可接受的酸盐,例如N-(1-辛基-4(1H)-吡啶亚胺基)辛基胺单盐酸盐,其作为抗微生物剂特别是针对生物组织和非生物表面,尤其是针对致病的牙齿微生物的有效成分,以及制备方法、使用方法和组合物。
  • Antimicrobial N-[1-(alkyl or
    申请人:Sterling Drug Inc.
    公开号:US04839372A1
    公开(公告)日:1989-06-13
    N-[1-alkyl or arylmethyl)-4(1H)-pyridinylidine]-alkanamine and pharmaceutically acceptable acid addition salts thereof, for example, N-(1-octyl-4(1H)-pyridinylidine)-octanamine monohydrochloride salt, which are useful as antimicrobial agents, especially on living tissues and nonliving surfaces and most especially against pathogenic dental microbes, and a process for perparation, methods of use and compositions thereof are disclosed.
    本发明涉及N-[1-烷基或芳基甲基)-4(1H)-吡啶烯]-烷基胺及其药学上可接受的酸盐加合物,例如N-(1-辛基-4(1H)-吡啶烯)-辛胺单盐酸盐,其作为抗微生物剂,特别是在活体组织和非活体表面上,尤其是对致病的牙齿微生物,以及其制备方法,使用方法和组合物。
  • Anti-microbial N-(1-(alkyl or arylmethyl)-4(1H)-pyridinylidine)alkanamines and acid addition salts thereof and process for preparation, methods of use and compositions thereof
    申请人:STERLING DRUG INC.
    公开号:EP0174632A1
    公开(公告)日:1986-03-19
    N-[1-(alkyl or arylmethyl)-4(1H)-pyridinylidine]alkanamine and pharmaceutically acceptable acid addition salts thereof, for example, N-(1-octyl-4(1H)-pyridinylidinel-octan- amine monohydrochloride salt, which are useful as antimicrobial agents, especially on living tissues and non-living surfaces and most especially against pathogenic dental microbes, and a process for preparation, methods of use and compositions thereof are disclosed.
    本发明公开了 N-[1-(烷基或芳基甲基)-4(1H)-吡啶基]烷胺及其药学上可接受的酸加成盐,例如 N-(1-辛基-4(1H)-吡啶基)辛胺单盐酸盐,它们可用作抗菌剂,特别是在生物组织和非生物表面上,尤其是针对牙科病原微生物,并公开了其制备工艺、使用方法和组合物。
  • Octendidine based compounds
    申请人:DISHMAN CARBOGEN AMCIS LTD.
    公开号:US11014907B2
    公开(公告)日:2021-05-25
    The present invention discloses Octenidine based compounds of formula (A) or formula (B) and formula (C) where in, n=1, 2, 3, 4 and R′=un-substituted or substituted aryl or alkyl group; R is hydroxy or hydrogen, X is chlorine, bromine and iodine. The present invention also relates to a process for the preparation thereof.
    本发明公开了式(A)或式(B)和式(C)的辛烯胺基化合物,其中,n=1、2、3、4,R′=未取代或取代的芳基或烷基;R为羟基或氢,X为。本发明还涉及其制备工艺。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-